下一个

自动播放

Chemotherapy Toxicity Considerations in Soft Tissue Sarcoma

0 意见 • 07/18/23
分享
嵌入
administrator
administrator
订户
0

The panelists, Brian Van Tine, MD, PhD; Robin Jones, MD, MRCP; Andrew Wagner, MD, PhD; Lor Randall, MD, FACS; Shreyaskumar Patel, MD; and Jonathan Trent, MD, PhD; discuss the factors they consider when balancing the risks and benefits of chemotherapy treatment in soft tissue sarcoma.

显示更多
0 注释 sort 排序方式
脸书评论

下一个

自动播放